午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) Struktur
CAS-Nr.
Englisch Name:
Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
Synonyma:
Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
CBNumber:
CB62567433
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) Eigenschaften

Sicherheit

HS Code  2914710000

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) Chemische Eigenschaften,Einsatz,Produktion Methoden

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Hao Zhun Biological Technology Co., Ltd. --
 info@zzsrm.com CHINA 6650 58
Whyte Chemicals --
 sales@whytechemicals.co.uk United Kingdom 3748 50
  • Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate)
Copyright 2019 ? ChemicalBook. All rights reserved